Daniel Eisenman
PhD, RBP, SM(NRCM), CBSP
Director, Biosafety Services, Advarra
Dr. Daniel Eisenman developed and manages Advarra's IBC service, coordinating with researchers the IRB and the NIH to help ensure gene therapy research is conducted safely and responsibly. He has served on multiple IBCs and BSL-3 oversight committees and has consulted for multiple IACUC committees.